ENGLEWOOD, Colo., May 3, 2023 /PRNewswire/ — Zynex, Inc. (“Zynex” or “the Company”) (Nasdaq: ZYXI), today announced the commencement of an underwritten public offering of 2,000,000 shares of its common stock by Thomas Sandgaard, its Chief Executive Officer (the “Secondary Offering”). Mr….
News
New Findings Indicate Metabolic Dysfunction As A Driver Of Immune Cell Attack To Brain Cells In Multiple Sclerosis
Researchers at the University of Colorado Anschutz Medical Campus are part of an international team that has discovered a molecular signature that plays a pivotal role in sustaining the activation of immune cells in chronic […]
News
FDA advisors unanimously reject Intarcia’s embattled type 2 diabetes treatment
I2o Therapeutics CEO Kurt Graves set out on Thursday to make a case to a panel of the FDA’s expert advisors that the benefits of his company’s twice-rejected implant to treat type 2 diabetes outweigh […]
News
TraceGains Marks Monumental 2023 with Accelerated Year-Over-Year Growth
The Industry’s Only Networked Ecosystem for the Food & Beverage Supply Chain Sets New Milestones, Reinforces Position as Premier Integrated Compliance and Product Development Solution Provider WESTMINSTER, Colo., Jan. 19, 2024 /PRNewswire/ — TraceGains has […]
